Seattle WA 黑色素瘤临床试验
16项针对 黑色素瘤的研究正在 Seattle及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
招募中3 期
- Swedish Cancer Institute, Seattle
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
招募中观察性研究欢迎健康志愿者
- Swedish Medical Center-Ballard Campus, Seattle
- Swedish Medical Center-Cherry Hill, Seattle
- Swedish Medical Center-First Hill, Seattle
- 以及另外 1 项
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
招募中观察性研究
- Swedish Medical Center-Ballard Campus, Seattle
- Kaiser Permanente Washington, Seattle
- Swedish Medical Center-First Hill, Seattle
A Study of Navlimetostat (BMS-986504) Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
招募中2 期
- Local Institution - 0086, Seattle
Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors
招募中1/2 期
- University of Washington Fred Hutchinson Cancer Center, Seattle
Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma
招募中3 期
- Fred Hutchinson Cancer Center, Seattle
- University of Washington Medical Center - Montlake, Seattle
- Saint Joseph Medical Center Hematology and Oncology - Silverdale, Silverdale · 距离 17 英里
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
招募中2 期
- Swedish Medical Center-Ballard Campus, Seattle
- Swedish Medical Center-Cherry Hill, Seattle
- Swedish Medical Center-First Hill, Seattle
Project: Every Child for Younger Patients With Cancer
招募中观察性研究
- Seattle Children's Hospital, Seattle
High-Intensity Exercise and High-Fiber Diet for Immunotherapy Outcomes in Melanoma Patients: The DUO Trial
招募中
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma, Hormone Receptor Positive HER2 Negative Metastatic Refractory Breast Cancer or Stage III-IV Non-Small Cell Lung Cancer
招募中1 期
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
招募中1/2 期
- Virginia Mason Medical Center, Seattle
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
招募中1/2 期
- Fred Hutchinson Cancer Center, Seattle
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
招募中2/3 期
- Fred Hutchinson Cancer Center, Seattle
Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)
招募中3 期
- Fred Hutchinson Cancer Center, Seattle
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
招募中观察性研究
- Massive Bio SYNERGY-AI site, Seattle
A Study of IBI363 in Subjects with Advanced Solid Malignancies
招募中2 期
- Fred Hutchinson Cancer Center, Seattle
其他城市的 黑色素瘤试验
- Houston, TX61 项研究
- New York City, NY41 项研究
- Nashville, TN34 项研究
- Los Angeles, CA34 项研究
- Pittsburgh, PA31 项研究
- Boston, MA25 项研究
- St. Louis, MO23 项研究
- Durham, NC22 项研究
- Philadelphia, PA22 项研究
- Tampa, FL21 项研究
- Columbus, OH21 项研究
- Dallas, TX21 项研究
Seattle的其他研究
- 非小细胞肺癌55 项研究
- 癌症（所有类型）48 项研究
- 前列腺癌45 项研究
- 急性髓系白血病40 项研究
- 转移性癌症39 项研究
- 乳腺癌37 项研究
- 结直肠癌35 项研究
- 肺癌34 项研究
- 卵巢癌29 项研究
- 胰腺癌22 项研究
- 多发性骨髓瘤22 项研究
- 急性淋巴细胞白血病22 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年11月15日。每项研究自行设定入选标准，由研究团队决定谁能参与。